Guest Editor Information Here you will find information about the Guest Editors for recent Special Series issues May 10, 2009 - Pediatric Cancer Survivorship: The Childhood Cancer Survivor Study Leslie L. Robison, PhD St. Jude Children’s Research Hospital, Memphis, TN Leslie L. Robison, PhD, obtained his under-graduate degree in Public Health from UCLA and subsequently completed MPH and PhD degrees in Public Health, and Epidemiology at the University of Minnesota. In 1984, he joined the faculty in the Department of Pediatrics at the University of Minnesota and later became Professor and Director of the Division of Pediatric Epidemiology and Clinical Research. Between 1998-2005 he served as Associate Director for Population Sciences in the University of Minnesota Comprehensive Cancer Center. In 2005, Dr. Robison moved to St. Jude Children’s Research Hospital to establish the Department of Epidemiology and Cancer Control and become the Associate Director for Cancer Prevention and Control in the St. Jude Children’s Cancer Center. He is the recipient of the ALSAC Endowed Chair in Epidemiology and Cancer Control. Dr. Robison is also an Adjunct Professor in the Department of Medicine at Vanderbilt University. Dr. Robison, a pediatric cancer epidemiologist has conducted large national epidemiologic studies of childhood cancer and is currently the principal investigator of the Childhood Cancer Survivor Study, a multi-institutional consortium – anchored at St. Jude – evaluating a cohort of more than 20,000 five-year survivors of childhood cancer. He also serves on the Scientific Council and Executive Committee of the Children’s Oncology Group (COG). He holds current positions on numerous national committees, task forces, councils and advisory boards in the fields of epidemiology, etiology, pediatric oncology and cancer survivorship. Dr. Robison is an author on more than 350 scientific publications. Melissa Hudson, MD St. Jude Children’s Research Hospital, Memphis, TN Melissa Hudson, MD, joined the St. Jude Children’s Research Hospital faculty in 1989. She is a Member and Director of the Cancer Survivorship Division in the Department of Oncology. For 15 years, Dr. Hudson served as the St. Jude principal investigator of the Pediatric Hodgkin’s Group trials, a multi-institutional consortium of investigators from St. Jude, Stanford University and Boston area hospitals. These trials evaluated risk-adapted, response-based combined modality therapy regimens designed to reduce organ dysfunction and subsequent malignancies in long-term survivors. Monitoring long-term health outcomes in children and adolescents with Hodgkin’s lymphoma evolved to a broader interest in late treatment complications after childhood cancer. Consequently, Dr. Hudson became the Director of the After Completion of Therapy (ACT) Clinic in 1993, which now supervises the care of over 5000 long-term childhood cancer survivors treated on St. Jude trials. During her tenure as Director, the ACT Clinic evaluation evolved to include a series of focused educational interventions aiming to increase survivor knowledge and cancer and its associated health risks and motivate the practice of health protective behaviors. The ACT Clinic has served as a paradigm of optimal risk-based survivor care, within a research setting, that provides a screening and prevention plan that integrates the cancer experience with health care needs. The ACT Clinic has also provided a forum for numerous research initiatives evaluating complications after childhood cancer and methods of health promotion. Dr. Hudson disseminated the St. Jude model of risk-based survivor care through her activities in the Children’s Oncology Group (COG) as Co-Chair of the COG Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancer. She is also the Chair of the Childhood Cancer Survivor Study (CCSS) Education Committee and Cancer Control Working Group. Dr. Hudson has collaborated with CCSS and COG investigators in a variety of health promotion initiatives targeting childhood cancer survivors. She has published widely on her research initiatives in pediatric Hodgkin's disease, late treatment sequelae after childhood cancer, and health education of childhood cancer survivors. Charles A. Sklar, MD Memorial Sloan-Kettering Cancer Center, New York, NY Charles A. Sklar, MD, did his undergraduate training at the George Washington University in Washington, D C. Dr. Sklar received his MD degree from the University Southern California. He completed a residency in Pediatrics at the Children’s Hospital of Los Angeles and a fellowship in Pediatric Endocrinology at the University of California, San Francisco. He was on the faculty in the Department of Pediatrics at the University of Minnesota from 1979-81 and the Department of Pediatrics at New York University from 1982 until 1990. Dr. Sklar joined the Department of Pediatrics at the Memorial Sloan-Kettering Cancer in 1991, where he is currently an Attending Pediatrician and the Director of the Long-Term Follow-Up Program. He is also a Professor of Pediatrics at the Weill Cornell College of Medicine. Dr. Sklar has a long-standing research interest in the endocrine complications of cancer therapy in survivors of childhood cancer. Areas of particular interest have included the late complications seen in survivors of stem cell transplantation and gonadal function and reproductive outcomes. He is currently a member of the Steering Committee for the Childhood Cancer Survivor Study. Most recently, he has been the principal investigator on studies examining the safety and efficacy of GH treatment in cancer survivors and the prevalence of and risk factors for primary ovarian insufficiency in female survivors of childhood cancer. Dr. Sklar has published widely on growth, endocrine, and reproductive outcomes in this population.